March 2025

NEWS & COLUMNS

6-7 NEWS
Novartis to acquire Anthos for $3.1bn; Roche’s SMA tablets granted FDA approval

8-9 NEWS
AstraZeneca’s late-stage results for camizestrant; Eli Lilly to invest $27bn in US manufacturing sites

10-11 DERMATOLOGY NEWS
EC approves Biocon’s Yesintek to treat psoriasis; BMS shares five-year results for Sotyktu

12 DARWIN'S MEDICINE
Innovation's one real law

13 HUMAN TOUCH IN AN AI WORLD
The robots aren’t taking over – but they do have the potential to elevate our profession

14 INNOVATIVE IMPACT
The AI advantage: seven steps to augmented pharma brand planning

15 CRITICAL THINKING
How AI tools are diminishing our engagement in deep, reflective thinking and learning processes

FEATURES

16-17 RARE DISEASES – IMPROVING PATIENT ACCESS
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts

21-23 PMLIVE’S TOP PHARMA LIST IS LIVE!
The List ranks the top companies in the pharmaceutical industry by their global sales, as well as by their revenues in the US, Europe and Japan

24-25 ALS – INNOVATIVE DEVELOPMENTS AND INVESTIGATIONAL TREATMENTS
Healthcare experts highlight revolutionary technological developments in ALS care

26 THE SOCIETY FOR ENDOCRINOLOGY CONFERENCE
Hypoparathyroidism causes a wide range of symptoms that can significantly impact patients’ overall health and well-being